Vericel Corp.

Vericel Corp.

Vericel Corp.

Overview
Date Founded

1989

Headquarters

64 Sidney Street, Cambridge, MA, 02139, USA

Type of Company

Public

Employees (Worldwide)

241

Industries

Pharmaceuticals
Biotechnology
Hospitals & Patient Services

Company Description

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Vericel Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Operating Officer

Secretary, Vice President & General Counsel

Chief Medical Officer

Benefit Plan Administrator

Senior Vice President, Commercial Operations

Head-Regulatory Affairs

Director Information Technology

Board of Directors

Co-Founder at QuatRx Pharmaceuticals Co.

Former Group Director at Pfizer Global Research & Development

Chief Financial Officer at Acceleron Pharma, Inc.

Chief Executive Officer, President & Director at Obsidian Therapeutics, Inc.

Chief Strategy Officer at Vineti, Inc.

President & Chief Executive Officer at Vericel Corp.

Paths to Vericel Corp.
Potential Connections via
Relationship Science
You
Vericel Corp.
Owners & Shareholders
Details Hidden

BCM provides investment services to clients on an individual basis, taking into consideration each client's investment objectives, goals, circumstances, and investment needs. When selecting securities and determining the total amount to be purchased or sold, the firm observes the investment policies, limitations and restrictions of the client accounts for which it advises. Their primary approach in evaluating securities is fundamental analysis. The investment strategy employed by BCM generally involves establishing long-term positions. The principal drivers for their sell discipline are: (1) when the fundamentals that spurred the original investment change adversely; (2) the security becomes overvalued, or; (3) it is determined that the security has been an investment mistake. Short sales, margin transactions and options (in all forms) are not utilized.

Details Hidden

RTW Investments employs an event-driven investment strategy that focuses on long/short investments in US healthcare companies. The firm invests primarily in the stocks of: (1) pharmaceutical companies (2) medical device manufacturers and (3) diagnostic tool manufacturers. RTW Investments also makes select investments in derivatives and fixed-income instruments.

Details Hidden

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment and philanthropy—all toward the end goal of cures for disease, improved quality of life and reduced cost of care. As of late 2019, the firm manages nearly $10 billion in assets. Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company. Having many years of operational expertise, Deerfielders are highly engaged and adept at navigating the complex crosscurrents ever-present in the healthcare and financial industries. Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.

Recent Transactions
Details Hidden

Vericel Corp. issued USD Common Stock

Details Hidden

Vericel Corp. issued USD Common Stock

Details Hidden

Vericel Corp. issued USD Common Stock

Transaction Advisors
Auditor

Advised onVericel Corp. issued USD Common Stock

Escrow Agent

Advised onVericel Corp. issued USD Common Stock

Underwriter

Advised onVericel Corp. issued USD Common Stock

Chair, Life Sciences Practice

Advised onVericel Corp. issued USD Common Stock

Managing Director

Advised onVericel Corp. issued USD Common Stock

Professional

Advised onVericel Corp. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, Los Angeles at Cooley LLP

Publicist

Managing Director at Solebury Trout LLC

Publicist
Key Stats and Financials As of 2019
Market Capitalization
$1.07B
Total Enterprise Value
$727M
Earnings Per Share
$-0.22
Revenue
$118M
Net Profit
$-9.66M
EBITDA
$-6.72M
EBITDAMargin
-5.7%
Total Debt
$27.9M
Total Equity
$111M
Enterprise Value / Sales
6.17x
TEVNet Income
-75.21x
Debt TEV
0.04x
Three Year Compounded Annual Growth Rate Of Revenue
29.41%
Non-Profit Donations & Grants
Investments
Details Hidden

RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI.

Suppliers
Matricel GmbH Medical Products & Equipment | Herzogenrath, Germany

Matricel GmbH develops, manufactures, and markets innovative medical devices and pharmaceutical excipients for applications in medicine and biotechnology. Its products include remaix, optimaix, and cartimaix. The company was founded in 2001 and is headquartered in Herzogenrath, Germany.

MediWound Ltd. Biotechnology | Yavne, Israel

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.

Omnicom Group, Inc. Consumer Services | New York, NY

Omnicom Group (NYSE: OMC) is a strategic holding company that manages a portfolio of global market leaders. Our companies operate in the disciplines of advertising, marketing services, specialty communications, interactive/digital media and media buying services.

Competitors
Zimmer Biomet Holdings, Inc. Medical Products & Equipment - Warsaw, IN

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Anika Therapeutics, Inc. Pharmaceuticals - Bedford, MA

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

AlloSource Retail: Other - Centennial, CO

AlloSource provides bone and tissue allografts. The firm offers orthobiologics, general orthopedic, large reconstructive, amniotic membrane, spinal, allofuse cervical grafts, burn and wound care products. The company was founded in 1994 and is headquartered in Centennial, CO.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vericel Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vericel Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vericel Corp..